David Sefrioui
Overview
Explore the profile of David Sefrioui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
655
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grancher A, Beaussire-Trouvay L, Vernon V, Dutherage M, Blondin V, Elie C, et al.
Br J Cancer
. 2025 Mar;
PMID: 40089635
Background: Circulating tumor DNA variations (∆ctDNA) were reported to be associated with treatment efficacy in metastatic colorectal cancer (mCRC). The present study evaluated ∆ctDNA according to first-line treatment intensity. Methods:...
2.
Hoba J, Grancher A, Hautefeuille V, Turpin A, Bouhier-Leporrier K, Galais M, et al.
Dig Liver Dis
. 2024 Jun;
57(1):30-37.
PMID: 38851974
Purpose: Relative dose intensity (RDI) is a measurement of chemotherapy (CT) dose defined as the actual dose received divided by the standard calculated dose during a set period. The study...
3.
Hautefeuille V, Williet N, Turpin A, Napoleon B, Dupre A, Huguet F, et al.
Dig Liver Dis
. 2024 Jun;
56(9):1452-1460.
PMID: 38845233
Background: Management of ampullary tumors (AT) is challenging because of a low level of scientific evidence. This document is a summary of the French intergroup guidelines regarding the management of...
4.
Grancher A, Cuissy S, Sefrioui D, Di Fiore F
Rev Prat
. 2024 May;
74(4):355-358.
PMID: 38814021
CONTRIBUTIONS OF MOLECULAR BIOLOGY TO THE MANAGEMENT OF COLORECTAL CANCER. Colorectal cancer (CRC) is a major public health problem affecting almost 43.000 people a year and causing 17.000 deaths. Advances...
5.
Marolleau P, Tougeron D, Allignet B, Cohen R, Sefrioui D, Gallet B, et al.
Int J Cancer
. 2023 Jul;
153(7):1376-1385.
PMID: 37403609
About 5% of the patients with metastatic colorectal cancers (mCRC) present microsatellite instability (MSI)/deficient mismatch repair system (dMMR). While metastasectomy is known to improve overall and progression-free survival in mCRC,...
6.
Zwart K, van der Baan F, Cohen R, Aparicio T, De La Fouchardiere C, Lecomte T, et al.
Cancer Med
. 2023 Jun;
12(15):15841-15853.
PMID: 37326121
Background: Current knowledge on prognostic biomarkers (especially BRAF /RAS mutations) in metastatic colorectal cancer (mCRC) is mainly based on mCRC patients with proficient mismatch repair (pMMR) tumors. It is uncertain...
7.
Grancher A, Beaussire L, Manfredi S, Le Malicot K, Dutherage M, Verdier V, et al.
Front Oncol
. 2022 Nov;
12:973167.
PMID: 36439476
Circulating tumor DNA (ctDNA) is reported to be promising in localized colorectal cancer (CRC). The present study aimed to retrospectively evaluate the impact of ctDNA in patients with a resected...
8.
Grancher A, Michel P, Di Fiore F, Sefrioui D
Cancer Biol Ther
. 2022 Jul;
23(1):446-461.
PMID: 35905195
Screening strategies have demonstrated their potential for decreasing the incidence and mortality of cancers, particularly that of colorectal cancer (CRC). Another strategy that has been developed to reduce CRC occurrence...
9.
Torregrosa C, Pernot S, Vaflard P, Perret A, Tournigand C, Randrian V, et al.
Int J Cancer
. 2022 Jul;
151(11):1978-1988.
PMID: 35833561
After failure of first line FOLFOX-bevacizumab for metastatic colorectal cancer (mCRC), adding either bevacizumab or aflibercept to second-line FOLFIRI increases survival compared to FOLFIRI alone. In this French retrospective multicentre...
10.
Javed S, Benoist S, Devos P, Truant S, Guimbaud R, Lievre A, et al.
World J Surg Oncol
. 2022 Apr;
20(1):131.
PMID: 35461290
Background: BRAF V600E-mutant colorectal cancers (CRCs) are associated with shorter survival than BRAF wild-type tumors. Therapeutic decision-making for colorectal liver metastases (CRLM) harboring this mutation remains difficult due to the...